New changes in novel coronavirus vaccination

In recent years, there have been some new changes in the work of novel coronavirus vaccination, and many people have raised some new questions

.

Here are the answers

.

Change 1: two people asked for one vaccine: is the efficacy guaranteed by this operation? A: before the small package was 0.5ml, now it is 1ml

.

This change is mainly to improve the production line speed, speed up production, and then meet the upcoming demand

.

It’s just a small package change

.

It’s still 0.5ml per person, which doesn’t affect any use effect

.

Therefore, there’s no need to worry about why the medical staff didn’t give you all the vaccines

.

Change 2: novel coronavirus vaccine can be mixed with different manufacturers

.

Question: is the effect of mixed vaccine the same? Is it safe? A: according to the technical guidelines for new coronavirus vaccination (First Edition), if the vaccine from the same manufacturer cannot continue to be supplied and the recipients can not be inoculated in other places, and the same vaccine product cannot be used to complete the vaccination, the vaccine products from other manufacturers of the same kind can be used to complete the vaccination

.

In other words, the first dose of new coronavirus vaccine from Beijing Institute of biology or Wuhan Institute of biology, and the second dose of new coronavirus vaccine from Beijing Kexing are no problem, because they are all the same type of vaccines, and they are all inactivated coronavirus vaccines, and vice versa

.

Change 3: the novel coronavirus vaccine appears in Lanzhou and other biological research institutes

.

Q: is it reliable to show the words Lanzhou, Changchun and Chengdu when inoculating the novel coronavirus vaccine in China? A: This is because Sinopharm has made overall arrangement of domestic resources to expand the production capacity of neocrown vaccine stock solution and the capacity of preparation packaging

.

Beijing Institute of biological products entrusted Lanzhou Institute of biological products, Chengdu Institute of biological products, Changchun Institute of biological products and other enterprises to undertake the packaging task of Xinguan vaccine preparation of Beijing Institute of biological products

.

The entrusted sub packaging operation is carried out in strict accordance with the relevant national laws and regulations

.

The vaccine stock solution is produced by Beijing Institute of biological products, and the quality of the vaccine produced and packaged by Beijing Institute of biological products is exactly the same, which has passed the regulatory certification of the relevant departments

.

The vaccine is also safe and controllable, and can be safely inoculated

.

Change 4: the interval between two injections is 3-8 weeks

.

Q: it was not 2-4 weeks before

.

Which time is right? A: after March 25, the state will adjust the time for two doses of the novel coronavirus vaccine to 3-8 weeks

.

If there is a saying of 2-4 weeks, it is that the local update is not timely

.

Change 5: new coronavirus mutates again Q: is it necessary to inoculate? A: virus mutation has always been a high concern of the state, vaccine R & D units and production units

.

Virus mutation is a global concern

.

From the global monitoring of virus mutation, there is no evidence that virus mutation will make the existing vaccine invalid

.

In any case, the mutated virus is only a part of the vaccine in China, which has been confirmed to have a good protective effect on the prevalent virus strains

.

We should be in the deployment of the country, as soon as possible vaccination of new coronavirus vaccine, rapid establishment of crowd immune barrier..

.